Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Accumulated Depreciation: 2024-2025

  • CG Oncology's Accumulated Depreciation was N/A to $623,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $623,000, marking a year-over-year change of. This contributed to the annual value of $87,000 for FY2024, which is N/A change from last year.
  • As of Q3 2025, CG Oncology's Accumulated Depreciation stood at $623,000, which was up 616.09% from $87,000 recorded in Q4 2024.
  • In the past 5 years, CG Oncology's Accumulated Depreciation ranged from a high of $623,000 in Q3 2025 and a low of $87,000 during Q4 2024.
  • For the 2-year period, CG Oncology's Accumulated Depreciation averaged around $355,000, with its median value being $355,000 (2024).